Cannabinoid [EPC]

Cannabinoid [EPC] was reported 8105 times

Drugs of the Cannabinoid [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 HYPOSPLENISM 8 0.2051
1 NAIL BED INFLAMMATION 29 0.0909
2 ASPLENIA 8 0.0808
3 CHILD NEGLECT 16 0.0664
4 NASAL MUCOSAL DISORDER 29 0.0497
5 NEUROMUSCULAR BLOCKADE 7 0.0312
6 CHILD ABUSE 8 0.0309
7 MUCOSAL INFECTION 7 0.0299
8 DRUG SCREEN POSITIVE 235 0.0297
9 STREPTOCOCCAL SEPSIS 34 0.0287
10 HOMICIDE 42 0.0228
11 MUSCLE MASS 10 0.0221
12 PSEUDOMONAL SEPSIS 36 0.0205
13 NEONATAL INFECTION 7 0.0202
14 ENTEROBACTER BACTERAEMIA 6 0.0198
15 VASCULAR DEVICE INFECTION 64 0.0141
16 MYOCARDIAL FIBROSIS 11 0.0131
17 FAILURE TO THRIVE 61 0.0117
18 DRUG DIVERSION 71 0.0115
19 TESTICULAR ATROPHY 10 0.0115
20 HYPERLIPASAEMIA 6 0.0115
21 DEFAECATION DISORDER 7 0.0104
22 BONE DEMINERALISATION 11 0.0104
23 B-LYMPHOCYTE COUNT DECREASED 13 0.0095
24 IMPAIRED DRIVING ABILITY 107 0.0094
25 PRODUCT TEMPERATURE EXCURSION ISSUE 46 0.0089
26 CARDIAC DEATH 10 0.0083
27 ARTERIOSCLEROSIS CORONARY ARTERY 52 0.0078
28 IMMUNE RECONSTITUTION SYNDROME 10 0.0077
29 POISONING 95 0.0076
30 SUBSTANCE ABUSE 61 0.0075
31 BRAIN OEDEMA 93 0.0074
32 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 39 0.0072
33 HANGOVER 25 0.0071
34 SOFT TISSUE INFECTION 13 0.0071
35 PARONYCHIA 31 0.0070
36 LARGE FOR DATES BABY 6 0.0068
37 ADENOCARCINOMA GASTRIC 6 0.0065
38 ASPHYXIA 52 0.0064
39 FANCONI SYNDROME 9 0.0064
40 PANCREATIC CARCINOMA METASTATIC 18 0.0063
41 VARICOSE VEIN 32 0.0062
42 NEUROGENIC BLADDER 13 0.0062
43 CARBON DIOXIDE DECREASED 7 0.0061
44 GUN SHOT WOUND 11 0.0058
45 VESTIBULAR DISORDER 7 0.0057
46 LOBAR PNEUMONIA 10 0.0054
47 METASTASES TO LYMPH NODES 36 0.0053
48 PHYSICAL ASSAULT 11 0.0053
49 DRUG LEVEL ABOVE THERAPEUTIC 24 0.0052
50 SUBSTANCE USE 8 0.0051
51 AUTONOMIC NERVOUS SYSTEM IMBALANCE 14 0.0048
52 GENERALISED ANXIETY DISORDER 7 0.0048
53 MALNUTRITION 52 0.0046
54 PRODUCT COUNTERFEIT 8 0.0046
55 COUNTERFEIT PRODUCT ADMINISTERED 6 0.0046
56 FANCONI SYNDROME ACQUIRED 8 0.0046
57 HYPOTONIA NEONATAL 7 0.0045
58 INAPPROPRIATE AFFECT 7 0.0044
59 THORACIC VERTEBRAL FRACTURE 13 0.0044
60 ACCIDENTAL POISONING 6 0.0044
61 METASTATIC RENAL CELL CARCINOMA 8 0.0044
62 RESPIRATORY DISORDER NEONATAL 7 0.0043
63 ECONOMIC PROBLEM 63 0.0042
64 MALIGNANT PLEURAL EFFUSION 7 0.0041
65 ORAL INTAKE REDUCED 10 0.0041
66 PARADOXICAL DRUG REACTION 15 0.0041
67 CERVICAL SPINAL STENOSIS 7 0.0041
68 HYPERPARATHYROIDISM SECONDARY 10 0.0040
69 CYSTIC FIBROSIS 22 0.0040
70 INTRACRANIAL PRESSURE INCREASED 22 0.0039
71 ESSENTIAL HYPERTENSION 7 0.0038
72 DRUG ABUSE 313 0.0038
73 CACHEXIA 19 0.0037
74 BONE MARROW TRANSPLANT 7 0.0037
75 METABOLIC ENCEPHALOPATHY 11 0.0037
76 HOSPICE CARE 36 0.0036
77 METASTASES TO CENTRAL NERVOUS SYSTEM 47 0.0036
78 OSTEOPENIA 55 0.0036
79 BRAIN DEATH 11 0.0036
80 DRUG TOLERANCE 18 0.0036
81 CANDIDA INFECTION 60 0.0035
82 ANHEDONIA 93 0.0035
83 CARBOHYDRATE ANTIGEN 125 INCREASED 12 0.0035
84 NEPHROGENIC ANAEMIA 16 0.0035
85 MUSCLE SPASTICITY 42 0.0034
86 KYPHOSIS 6 0.0034
87 WOUND DEHISCENCE 11 0.0033
88 IRON DEFICIENCY ANAEMIA 30 0.0032
89 SPUTUM INCREASED 7 0.0032
90 ACCIDENTAL DEATH 6 0.0032
91 GASTRIC INFECTION 12 0.0031
92 CANCER PAIN 8 0.0031
93 ATELECTASIS 30 0.0031
94 RESPIRATORY DEPRESSION 38 0.0031
95 LEFT VENTRICULAR HYPERTROPHY 13 0.0030
96 RENAL FUNCTION TEST ABNORMAL 14 0.0030
97 MYCOBACTERIUM AVIUM COMPLEX INFECTION 8 0.0030
98 PANCREATITIS CHRONIC 7 0.0030
99 CATHETER SITE INFECTION 11 0.0029
100 PRODUCT PRESCRIBING ISSUE 63 0.0029
101 SKIN HYPERTROPHY 8 0.0028
102 LOGORRHOEA 10 0.0028
103 PERFORMANCE STATUS DECREASED 13 0.0028
104 JAW FRACTURE 6 0.0028
105 METASTASES TO PERITONEUM 7 0.0028
106 OESOPHAGEAL CANDIDIASIS 11 0.0028
107 PRE-EXISTING CONDITION IMPROVED 17 0.0027
108 CLOSTRIDIUM TEST POSITIVE 6 0.0027
109 IMMUNE-MEDIATED ENTEROCOLITIS 10 0.0027
110 ABDOMINAL ABSCESS 12 0.0027
111 BLOOD CULTURE POSITIVE 8 0.0027
112 CHRONIC GASTRITIS 6 0.0027
113 BRADYPNOEA 7 0.0026
114 HYPOPHAGIA 66 0.0026
115 SPINAL CORD COMPRESSION 10 0.0026
116 APPETITE DISORDER 17 0.0026
117 ARTERIOSCLEROSIS 24 0.0025
118 NON-CARDIAC CHEST PAIN 8 0.0025
119 NON-SMALL CELL LUNG CANCER 12 0.0025
120 MENTAL STATUS CHANGES 68 0.0024
121 BEHAVIOUR DISORDER 13 0.0024
122 CHEILITIS 13 0.0024
123 URINE ANALYSIS ABNORMAL 7 0.0023
124 HYPOALBUMINAEMIA 18 0.0023
125 HICCUPS 19 0.0023
126 STAPHYLOCOCCAL BACTERAEMIA 10 0.0023
127 INCONTINENCE 24 0.0023
128 FULL BLOOD COUNT ABNORMAL 24 0.0023
129 EUPHORIC MOOD 23 0.0022
130 TRIGEMINAL NEURALGIA 9 0.0022
131 BLOOD MAGNESIUM DECREASED 19 0.0022
132 SUBSTANCE USE DISORDER 7 0.0022
133 APHTHOUS ULCER 17 0.0022
134 DEHYDRATION 289 0.0022
135 THROMBOSIS IN DEVICE 7 0.0021
136 DECREASED ACTIVITY 23 0.0021
137 PROTEIN TOTAL DECREASED 8 0.0021
138 ACUTE LYMPHOCYTIC LEUKAEMIA 6 0.0021
139 FACE INJURY 8 0.0021
140 TOXICITY TO VARIOUS AGENTS 353 0.0021
141 BLOOD LACTIC ACID INCREASED 11 0.0021
142 METASTATIC NEOPLASM 9 0.0021
143 METASTASES TO SPINE 7 0.0021
144 LUNG CANCER METASTATIC 6 0.0021
145 BONE DENSITY DECREASED 65 0.0021
146 HYPOVOLAEMIA 12 0.0020
147 PNEUMONIA FUNGAL 8 0.0020
148 HYPOKALAEMIA 93 0.0020
149 HYPERLIPIDAEMIA 24 0.0020
150 PLEURAL EFFUSION 121 0.0020
151 NEPHROGENIC SYSTEMIC FIBROSIS 6 0.0020
152 PULMONARY OEDEMA 88 0.0020
153 RECURRENT CANCER 8 0.0020
154 DECREASED APPETITE 455 0.0020
155 PNEUMOTHORAX 31 0.0020
156 REBOUND EFFECT 22 0.0019
157 BRAIN NATRIURETIC PEPTIDE INCREASED 6 0.0019
158 DIASTOLIC DYSFUNCTION 6 0.0019
159 PERIPHERAL VASCULAR DISORDER 10 0.0019
160 BONE LESION 7 0.0019
161 RED CELL DISTRIBUTION WIDTH INCREASED 8 0.0019
162 PARANOIA 33 0.0019
163 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 13 0.0019
164 BLOOD SODIUM DECREASED 36 0.0019
165 GASTROINTESTINAL INFECTION 17 0.0019
166 OSTEOPOROSIS 78 0.0019
167 ESCHERICHIA URINARY TRACT INFECTION 8 0.0019
168 SPINAL PAIN 22 0.0019
169 FAECAL INCONTINENCE 9 0.0019
170 LUNG NEOPLASM 8 0.0019
171 BLOOD CALCIUM DECREASED 21 0.0019
172 BRADYKINESIA 11 0.0019
173 ANOREXIA 24 0.0019
174 LOOSE TOOTH 6 0.0019
175 DYSARTHRIA 70 0.0019
176 RESTLESSNESS 68 0.0019
177 GINGIVITIS 10 0.0019
178 HEPATIC LESION 8 0.0018
179 ROAD TRAFFIC ACCIDENT 77 0.0018
180 INFUSION SITE HAEMORRHAGE 6 0.0018
181 METASTASES TO LIVER 32 0.0018
182 HAEMATOCRIT DECREASED 36 0.0018
183 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 6 0.0018
184 CARDIOPULMONARY FAILURE 7 0.0018
185 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 9 0.0018
186 SCOLIOSIS 11 0.0018
187 PATHOLOGICAL FRACTURE 9 0.0018
188 ILEUS 22 0.0018
189 BACTERAEMIA 21 0.0018
190 IMPAIRED GASTRIC EMPTYING 24 0.0018
191 OBSTRUCTION 7 0.0018
192 ORAL CANDIDIASIS 23 0.0017
193 CARDIO-RESPIRATORY ARREST 73 0.0017
194 LUNG INFECTION 27 0.0017
195 BLOOD URIC ACID INCREASED 10 0.0017
196 MULTIPLE MYELOMA 8 0.0017
197 LEUKOCYTOSIS 31 0.0017
198 ABNORMAL FAECES 14 0.0017
199 OBSTRUCTIVE AIRWAYS DISORDER 19 0.0017
200 EMBOLIC STROKE 6 0.0017
201 BLOOD BILIRUBIN INCREASED 46 0.0017
202 LUNG TRANSPLANT 6 0.0017
203 BREAST CANCER METASTATIC 18 0.0017
204 ODYNOPHAGIA 10 0.0017
205 SUPRAVENTRICULAR TACHYCARDIA 16 0.0017
206 PULMONARY CONGESTION 22 0.0017
207 ANAL INCONTINENCE 15 0.0017
208 TUMOUR MARKER INCREASED 8 0.0017
209 AGGRESSION 83 0.0017
210 ASPIRATION 18 0.0016
211 MAJOR DEPRESSION 12 0.0016
212 BLOOD ALBUMIN DECREASED 13 0.0016
213 SKIN FISSURES 32 0.0016
214 DRUG LEVEL INCREASED 27 0.0016
215 ORAL PAIN 36 0.0016
216 RIB FRACTURE 33 0.0016
217 HYDRONEPHROSIS 12 0.0016
218 LYMPHOEDEMA 11 0.0016
219 END STAGE RENAL DISEASE 29 0.0016
220 FEEDING DISORDER 32 0.0016
221 SPINAL COMPRESSION FRACTURE 13 0.0016
222 SEPSIS 175 0.0016
223 FEBRILE NEUTROPENIA 104 0.0016
224 CLAVICLE FRACTURE 6 0.0016
225 MUSCULOSKELETAL CHEST PAIN 24 0.0015
226 PRODUCT SUPPLY ISSUE 11 0.0015
227 HEPATOMEGALY 15 0.0015
228 WEIGHT DECREASED 422 0.0015
229 RENAL CYST 12 0.0015
230 CLOSTRIDIUM DIFFICILE COLITIS 16 0.0015
231 ACUTE RESPIRATORY FAILURE 29 0.0015
232 PROTHROMBIN TIME PROLONGED 9 0.0015
233 FLANK PAIN 14 0.0015
234 PLASMA CELL MYELOMA 58 0.0015
235 SEASONAL ALLERGY 21 0.0015
236 METASTASES TO LUNG 17 0.0015
237 GOITRE 6 0.0015
238 METASTASES TO BONE 24 0.0015
239 HYPERCALCAEMIA 18 0.0015
240 PRESCRIBED UNDERDOSE 29 0.0015
241 BLOOD COUNT ABNORMAL 22 0.0014
242 HYPOXIA 51 0.0014
243 VITAMIN D DEFICIENCY 14 0.0014
244 DEVICE RELATED INFECTION 22 0.0014
245 CLOSTRIDIUM DIFFICILE INFECTION 31 0.0014
246 HAND FRACTURE 10 0.0014
247 SINUS TACHYCARDIA 20 0.0014
248 SEROTONIN SYNDROME 27 0.0014
249 DISEASE PROGRESSION 166 0.0014
250 GAMMA-GLUTAMYLTRANSFERASE INCREASED 31 0.0014
251 HYPERTONIA 8 0.0014
252 UNRESPONSIVE TO STIMULI 36 0.0014
253 TOXIC ENCEPHALOPATHY 7 0.0014
254 SMALL INTESTINAL OBSTRUCTION 17 0.0014
255 ORTHOSTATIC HYPOTENSION 24 0.0014
256 ELECTROLYTE IMBALANCE 16 0.0014
257 MALIGNANT NEOPLASM PROGRESSION 141 0.0014
258 NEUTROPHIL COUNT DECREASED 56 0.0014
259 BLOOD ALKALINE PHOSPHATASE INCREASED 34 0.0014
260 NEURALGIA 33 0.0014
261 CHRONIC KIDNEY DISEASE 103 0.0014
262 PLEURISY 8 0.0013
263 POST-TRAUMATIC STRESS DISORDER 9 0.0013
264 FISTULA 15 0.0013
265 IRON DEFICIENCY 6 0.0013
266 TASTE DISORDER 27 0.0013
267 FOOD CRAVING 7 0.0013
268 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 31 0.0013
269 RENAL TUBULAR NECROSIS 13 0.0013
270 PANCYTOPENIA 74 0.0013
271 RETCHING 28 0.0013
272 PERIPHERAL COLDNESS 18 0.0013
273 GASTROINTESTINAL MOTILITY DISORDER 7 0.0013
274 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
275 COMPRESSION FRACTURE 7 0.0013
276 LIPASE INCREASED 10 0.0013
277 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 8 0.0013
278 RED BLOOD CELL COUNT DECREASED 37 0.0013
279 GENERALISED OEDEMA 16 0.0013
280 CHOLANGITIS 8 0.0013
281 FULL BLOOD COUNT DECREASED 26 0.0013
282 PULMONARY HAEMORRHAGE 10 0.0013
283 NEOPLASM PROGRESSION 44 0.0013
284 BLOOD POTASSIUM DECREASED 38 0.0013
285 ENCEPHALOPATHY 31 0.0013
286 VOMITING 593 0.0013
287 NEUTROPENIC SEPSIS 9 0.0013
288 ASCITES 37 0.0013
289 STREPTOCOCCAL INFECTION 7 0.0013
290 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 12 0.0013
291 SCREAMING 8 0.0013
292 ATRIAL FLUTTER 10 0.0013
293 STOMATITIS 76 0.0013
294 TACHYPNOEA 17 0.0012
295 AGITATION 91 0.0012
296 CARDIOTOXICITY 11 0.0012
297 BACTERIAL INFECTION 23 0.0012
298 TUBULOINTERSTITIAL NEPHRITIS 23 0.0012
299 REFUSAL OF TREATMENT BY PATIENT 8 0.0012
300 CARDIOMEGALY 15 0.0012
301 MULTIPLE FRACTURES 20 0.0012
302 ESCHERICHIA INFECTION 10 0.0012
303 PNEUMONITIS 33 0.0012
304 DELIRIUM 42 0.0012
305 ABDOMINAL TENDERNESS 6 0.0012
306 HYPERNATRAEMIA 6 0.0012
307 AGEUSIA 30 0.0012
308 FLUID INTAKE REDUCED 6 0.0012
309 PNEUMONIA BACTERIAL 11 0.0012
310 THROMBOCYTOPENIA 134 0.0012
311 SKIN LACERATION 13 0.0012
312 BRONCHIECTASIS 8 0.0012
313 MUCOSAL INFLAMMATION 31 0.0012
314 URINARY INCONTINENCE 35 0.0012
315 CONFUSIONAL STATE 190 0.0012
316 HIATUS HERNIA 15 0.0012
317 ORAL DISCOMFORT 16 0.0012
318 HYPOMAGNESAEMIA 16 0.0011
319 MALABSORPTION 6 0.0011
320 PULMONARY MASS 17 0.0011
321 DEEP VEIN THROMBOSIS 74 0.0011
322 NAUSEA 901 0.0011
323 PLATELET COUNT DECREASED 121 0.0011
324 IMMUNOSUPPRESSION 10 0.0011
325 BONE LOSS 17 0.0011
326 HAEMOGLOBIN DECREASED 116 0.0011
327 EATING DISORDER 24 0.0011
328 RESPIRATORY ARREST 31 0.0011
329 MIOSIS 9 0.0011
330 METASTASIS 8 0.0011
331 URINARY TRACT INFECTION 190 0.0011
332 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 58 0.0011
333 SPLENOMEGALY 13 0.0011
334 TOOTH LOSS 23 0.0011
335 PANIC REACTION 8 0.0011
336 C-REACTIVE PROTEIN INCREASED 40 0.0011
337 WHITE BLOOD CELL COUNT DECREASED 119 0.0011
338 BONE DISORDER 20 0.0011
339 WHITE BLOOD CELL COUNT ABNORMAL 7 0.0011
340 CYTOKINE RELEASE SYNDROME 22 0.0011
341 MYOCLONUS 13 0.0011
342 PROCTALGIA 7 0.0011
343 EMBOLISM 9 0.0011
344 HYPERTENSIVE CRISIS 12 0.0011
345 HEART RATE ABNORMAL 6 0.0011
346 HAEMOPTYSIS 30 0.0011
347 NODULE 14 0.0011
348 RESPIRATORY FAILURE 78 0.0011
349 POLYP 7 0.0011
350 SOMNAMBULISM 7 0.0011
351 DEVICE OCCLUSION 15 0.0011
352 HYPERBILIRUBINAEMIA 11 0.0011
353 DERMATITIS CONTACT 12 0.0011
354 PSYCHOTIC DISORDER 31 0.0010
355 HYPONATRAEMIA 59 0.0010
356 TERMINAL STATE 7 0.0010
357 ATRIOVENTRICULAR BLOCK COMPLETE 7 0.0010
358 QUALITY OF LIFE DECREASED 14 0.0010
359 RENAL FAILURE CHRONIC 8 0.0010
360 PYELONEPHRITIS 9 0.0010
361 COLITIS 39 0.0010
362 BODY HEIGHT DECREASED 11 0.0010
363 APNOEA 8 0.0010
364 MUSCLE ATROPHY 13 0.0010
365 HYPERTRIGLYCERIDAEMIA 6 0.0010
366 ASTHENIA 384 0.0010
367 ECCHYMOSIS 7 0.0010
368 DECREASED IMMUNE RESPONSIVENESS 10 0.0010
369 LYMPHOCYTE COUNT DECREASED 18 0.0010
370 CONSTIPATION 222 0.0010
371 ONYCHOCLASIS 7 0.0010
372 HYPERGLYCAEMIA 37 0.0010
373 RENAL FAILURE ACUTE 43 0.0010
374 GALLBLADDER DISORDER 18 0.0010
375 HAEMOLYTIC ANAEMIA 9 0.0010
376 MULTIPLE SCLEROSIS 48 0.0010
377 ABSCESS 16 0.0010
378 GASTROINTESTINAL PAIN 11 0.0010
379 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 48 0.0010
380 SLEEP DISORDER 70 0.0010
381 ADRENAL INSUFFICIENCY 12 0.0010
382 DEPRESSED LEVEL OF CONSCIOUSNESS 39 0.0010
383 ABDOMINAL PAIN 229 0.0010
384 PANCREATITIS 52 0.0010
385 TOOTH ABSCESS 10 0.0010
386 CONVULSION 56 0.0010
387 POLYURIA 8 0.0010
388 HYPERAESTHESIA 8 0.0010
389 GRAFT VERSUS HOST DISEASE 7 0.0010
390 TONGUE DISORDER 7 0.0010
391 EMOTIONAL DISTRESS 117 0.0010
392 HAIR COLOUR CHANGES 12 0.0010
393 ACUTE MYELOID LEUKAEMIA 15 0.0010
394 DIARRHOEA 620 0.0010
395 ANAEMIA 183 0.0010
396 PNEUMONIA 309 0.0010
397 WITHDRAWAL SYNDROME 40 0.0010
398 BACK PAIN 221 0.0010
399 HYPOCALCAEMIA 18 0.0010
400 HYPOPHOSPHATAEMIA 7 0.0009
401 JOINT DISLOCATION 10 0.0009
402 PROSTATIC SPECIFIC ANTIGEN INCREASED 13 0.0009
403 COGNITIVE DISORDER 44 0.0009
404 ASPARTATE AMINOTRANSFERASE INCREASED 50 0.0009
405 STAPHYLOCOCCAL INFECTION 31 0.0009
406 HYPOTHYROIDISM 30 0.0009
407 OSTEOMYELITIS 17 0.0009
408 ENTERITIS 6 0.0009
409 VITAMIN D DECREASED 8 0.0009
410 HAEMOGLOBIN ABNORMAL 6 0.0009
411 BODY TEMPERATURE INCREASED 19 0.0009
412 ANXIETY 265 0.0009
413 SINUS BRADYCARDIA 9 0.0009
414 MASS 13 0.0009
415 ATAXIA 11 0.0009
416 BONE PAIN 54 0.0009
417 FATIGUE 717 0.0009
418 TROPONIN INCREASED 7 0.0009
419 BIPOLAR DISORDER 10 0.0009
420 VERTIGO 56 0.0009
421 POLYNEUROPATHY 11 0.0009
422 BRADYPHRENIA 6 0.0009
423 FLATULENCE 52 0.0009
424 HYPOGAMMAGLOBULINAEMIA 6 0.0009
425 GASTRITIS 24 0.0009
426 SPINAL OSTEOARTHRITIS 8 0.0009
427 PERICARDIAL EFFUSION 21 0.0009
428 CORONAVIRUS INFECTION 6 0.0009
429 HAEMATEMESIS 23 0.0009
430 FOOD ALLERGY 7 0.0009
431 NOCTURIA 11 0.0009
432 ANKLE FRACTURE 14 0.0009
433 DENTAL CARIES 10 0.0009
434 PELVIC FRACTURE 7 0.0009
435 FOOT FRACTURE 17 0.0009
436 FACIAL PAIN 8 0.0009
437 COMPLICATION ASSOCIATED WITH DEVICE 13 0.0009
438 GASTROINTESTINAL INFLAMMATION 7 0.0009
439 MULTIPLE ALLERGIES 7 0.0009
440 EMPHYSEMA 9 0.0009
441 THERAPEUTIC RESPONSE DECREASED 54 0.0009
442 DISTURBANCE IN ATTENTION 48 0.0009
443 RENAL FAILURE 118 0.0009
444 CYST 11 0.0009
445 WHITE BLOOD CELL COUNT INCREASED 34 0.0009
446 GASTROENTERITIS VIRAL 16 0.0009
447 DYSKINESIA 36 0.0009
448 HEMIPARESIS 15 0.0009
449 DYSPHAGIA 84 0.0009
450 TRICUSPID VALVE INCOMPETENCE 7 0.0009
451 ABNORMAL LOSS OF WEIGHT 6 0.0009
452 EXOSTOSIS 8 0.0009
453 MICTURITION URGENCY 10 0.0009
454 ACCIDENTAL OVERDOSE 32 0.0009
455 SOMNOLENCE 176 0.0009
456 TEMPERATURE INTOLERANCE 9 0.0009
457 BRAIN NEOPLASM 8 0.0009
458 DEPRESSION 198 0.0009
459 LETHARGY 50 0.0009
460 ACUTE KIDNEY INJURY 133 0.0009
461 RHINITIS 7 0.0009
462 GRAND MAL CONVULSION 8 0.0009
463 DIVERTICULITIS 24 0.0009
464 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
465 LARGE INTESTINE PERFORATION 6 0.0009
466 PERSONALITY CHANGE 8 0.0009
467 LACRIMATION INCREASED 26 0.0009
468 DECUBITUS ULCER 7 0.0009
469 HEPATIC STEATOSIS 16 0.0009
470 TRANSFUSION 9 0.0009
471 MYDRIASIS 11 0.0009
472 NEUROPATHY PERIPHERAL 81 0.0009
473 HAIR DISORDER 7 0.0008
474 OSTEONECROSIS OF JAW 21 0.0008
475 VENTRICULAR TACHYCARDIA 14 0.0008
476 PAIN IN JAW 24 0.0008
477 LABORATORY TEST ABNORMAL 25 0.0008
478 GENERALISED TONIC-CLONIC SEIZURE 14 0.0008
479 FRACTURE 16 0.0008
480 MENSTRUAL DISORDER 7 0.0008
481 DIVERTICULUM 6 0.0008
482 SECOND PRIMARY MALIGNANCY 7 0.0008
483 FUNGAL INFECTION 28 0.0008
484 LEUKOPENIA 42 0.0008
485 SUBDURAL HAEMATOMA 12 0.0008
486 NIGHT SWEATS 27 0.0008
487 INCREASED APPETITE 16 0.0008
488 OEDEMA PERIPHERAL 102 0.0008
489 WRIST FRACTURE 10 0.0008
490 DISORIENTATION 33 0.0008
491 PULMONARY EMBOLISM 79 0.0008
492 HYPERCHOLESTEROLAEMIA 8 0.0008
493 SEPTIC SHOCK 36 0.0008
494 OSTEOARTHRITIS 35 0.0008
495 DIZZINESS POSTURAL 8 0.0008
496 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 14 0.0008
497 MUSCLE TWITCHING 19 0.0008
498 UPPER RESPIRATORY TRACT INFECTION 38 0.0008
499 DRUG INTERACTION 130 0.0008
500 MOUTH HAEMORRHAGE 6 0.0008
501 HYPOTENSION 164 0.0008
502 MULTIPLE SCLEROSIS RELAPSE 56 0.0008
503 PSEUDOMONAS INFECTION 7 0.0008
504 PULMONARY HYPERTENSION 17 0.0008
505 VITREOUS FLOATERS 8 0.0008
506 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
507 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0008
508 TRANSAMINASES INCREASED 18 0.0008
509 ACTIVITIES OF DAILY LIVING IMPAIRED 16 0.0008
510 SINUS DISORDER 16 0.0008
511 IMMUNODEFICIENCY 12 0.0008
512 TOOTH EXTRACTION 10 0.0008
513 MUSCLE TIGHTNESS 13 0.0008
514 EPISTAXIS 60 0.0008
515 NEUTROPENIA 109 0.0008
516 SPEECH DISORDER 42 0.0008
517 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
518 PNEUMONIA ASPIRATION 20 0.0008
519 GROIN PAIN 7 0.0008
520 SEIZURE 92 0.0008
521 TUMOUR LYSIS SYNDROME 7 0.0008
522 LUNG INFILTRATION 7 0.0008
523 RESPIRATORY RATE INCREASED 7 0.0008
524 APHONIA 11 0.0008
525 LOCALISED INFECTION 19 0.0008
526 MENTAL IMPAIRMENT 19 0.0008
527 DISSOCIATION 6 0.0008
528 ABNORMAL BEHAVIOUR 31 0.0008
529 GOUT 14 0.0008
530 INITIAL INSOMNIA 8 0.0008
531 SYNCOPE 78 0.0008
532 PARALYSIS 11 0.0008
533 HAEMORRHAGIC STROKE 6 0.0008
534 TENDERNESS 8 0.0008
535 PLATELET COUNT INCREASED 10 0.0008
536 PETECHIAE 8 0.0008
537 WEIGHT FLUCTUATION 8 0.0008
538 HEPATIC FAILURE 23 0.0008
539 INSOMNIA 203 0.0008
540 PANCREATIC CARCINOMA 22 0.0008
541 APHASIA 23 0.0008
542 MYELODYSPLASTIC SYNDROME 11 0.0008
543 LIVER FUNCTION TEST ABNORMAL 22 0.0008
544 DYSGEUSIA 56 0.0008
545 UPPER LIMB FRACTURE 15 0.0008
546 DRY MOUTH 61 0.0008
547 ELECTROCARDIOGRAM QT PROLONGED 27 0.0007
548 HEPATIC ENCEPHALOPATHY 7 0.0007
549 NEPHROPATHY 7 0.0007
550 SPINAL FRACTURE 15 0.0007
551 ECZEMA 39 0.0007
552 LIVER FUNCTION TEST INCREASED 16 0.0007
553 NEUROTOXICITY 13 0.0007
554 MUSCLE DISORDER 6 0.0007
555 PANIC ATTACK 27 0.0007
556 CARDIAC ARREST 61 0.0007
557 ALTERED STATE OF CONSCIOUSNESS 16 0.0007
558 HEART RATE INCREASED 73 0.0007
559 GASTRIC ULCER 14 0.0007
560 CELLULITIS 37 0.0007
561 HYPERSOMNIA 21 0.0007
562 GINGIVAL BLEEDING 10 0.0007
563 HALLUCINATION 55 0.0007
564 RESPIRATORY TRACT INFECTION 19 0.0007
565 MANIA 12 0.0007
566 FLUID RETENTION 37 0.0007
567 AFFECT LABILITY 7 0.0007
568 BLOOD PRESSURE DECREASED 48 0.0007
569 PAIN 443 0.0007
570 COAGULOPATHY 12 0.0007
571 BLOOD CREATININE INCREASED 47 0.0007
572 INSURANCE ISSUE 11 0.0007
573 GENERAL PHYSICAL HEALTH DETERIORATION 83 0.0007
574 COORDINATION ABNORMAL 10 0.0007
575 DYSPNOEA EXERTIONAL 27 0.0007
576 THYROID DISORDER 11 0.0007
577 INTESTINAL PERFORATION 8 0.0007
578 LYMPHOMA 11 0.0007
579 INFUSION SITE ERYTHEMA 6 0.0007
580 ABDOMINAL PAIN UPPER 146 0.0007
581 CHROMATURIA 16 0.0007
582 EJECTION FRACTION DECREASED 11 0.0007
583 LYMPHOPENIA 10 0.0007
584 DYSURIA 26 0.0007
585 DIALYSIS 10 0.0007
586 MYOCARDIAL ISCHAEMIA 8 0.0007
587 DEATH 604 0.0007
588 HAEMATURIA 24 0.0007
589 OSTEONECROSIS 23 0.0007
590 GAIT DISTURBANCE 134 0.0007
591 LIMB INJURY 19 0.0007
592 INFUSION SITE PAIN 9 0.0007
593 NEPHROLITHIASIS 32 0.0007
594 PNEUMOCYSTIS JIROVECII PNEUMONIA 7 0.0007
595 NEOPLASM 8 0.0007
596 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
597 CARDIAC MURMUR 6 0.0007
598 HEPATIC CIRRHOSIS 13 0.0007
599 AMNESIA 45 0.0007
600 HYPOTHERMIA 7 0.0007
601 FALL 230 0.0007
602 THERAPEUTIC RESPONSE UNEXPECTED 31 0.0007
603 PYREXIA 239 0.0007
604 COVID-19 121 0.0007
605 HYPOKINESIA 10 0.0007
606 TACHYCARDIA 61 0.0007
607 CONTUSION 66 0.0007
608 SENSORY DISTURBANCE 11 0.0007
609 GASTROENTERITIS 10 0.0007
610 HYPERKALAEMIA 24 0.0007
611 HIP FRACTURE 22 0.0007
612 DYSPNOEA 387 0.0007
613 GASTROOESOPHAGEAL REFLUX DISEASE 55 0.0007
614 GRIP STRENGTH DECREASED 6 0.0007
615 DRUG DEPENDENCE 109 0.0007
616 CARDIOMYOPATHY 10 0.0007
617 LOWER LIMB FRACTURE 13 0.0007
618 LUNG DISORDER 33 0.0007
619 CHOLECYSTITIS 8 0.0007
620 THROMBOSIS 54 0.0007
621 ABDOMINAL DISTENSION 70 0.0007
622 ALANINE AMINOTRANSFERASE INCREASED 41 0.0007
623 OVERDOSE 144 0.0007
624 PRODUCT TASTE ABNORMAL 9 0.0007
625 BRONCHITIS 49 0.0007
626 BLOOD UREA INCREASED 11 0.0007
627 HAEMATOMA 17 0.0007
628 CYTOPENIA 8 0.0007
629 HEREDITARY ANGIOEDEMA 7 0.0007
630 RESPIRATORY DISTRESS 18 0.0007
631 INCREASED TENDENCY TO BRUISE 6 0.0007
632 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
633 LYMPHADENOPATHY 23 0.0006
634 INFECTION 94 0.0006
635 SPINAL OPERATION 8 0.0006
636 COMPLETED SUICIDE 54 0.0006
637 ATRIAL FIBRILLATION 63 0.0006
638 OEDEMA 35 0.0006
639 DEMENTIA 18 0.0006
640 CARPAL TUNNEL SYNDROME 9 0.0006
641 MUSCULAR WEAKNESS 73 0.0006
642 DEFORMITY 6 0.0006
643 BLOOD TEST ABNORMAL 9 0.0006
644 CHILLS 75 0.0006
645 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
646 TOOTH FRACTURE 7 0.0006
647 JAUNDICE 17 0.0006
648 URINARY RETENTION 21 0.0006
649 SLEEP APNOEA SYNDROME 12 0.0006
650 SINUSITIS 64 0.0006
651 ANOSMIA 9 0.0006
652 UNEVALUABLE EVENT 47 0.0006
653 HERNIA 12 0.0006
654 MENTAL DISORDER 27 0.0006
655 DYSTONIA 12 0.0006
656 MITRAL VALVE INCOMPETENCE 7 0.0006
657 FLUID OVERLOAD 9 0.0006
658 THIRST 11 0.0006
659 AUTOIMMUNE DISORDER 6 0.0006
660 GASTROINTESTINAL DISORDER 55 0.0006
661 OCULAR HYPERAEMIA 29 0.0006
662 INFLUENZA 68 0.0006
663 BODY TEMPERATURE DECREASED 6 0.0006
664 SKIN DISCOLOURATION 28 0.0006
665 TOOTH INFECTION 8 0.0006
666 LIGAMENT SPRAIN 6 0.0006
667 RENAL INJURY 18 0.0006
668 PELVIC PAIN 11 0.0006
669 INTENTIONAL PRODUCT MISUSE 53 0.0006
670 BLADDER DISORDER 6 0.0006
671 INABILITY TO AFFORD MEDICATION 6 0.0006
672 COLON CANCER 9 0.0006
673 BALANCE DISORDER 52 0.0006
674 HYPOTONIA 6 0.0006
675 HEAD INJURY 19 0.0006
676 OFF LABEL USE 523 0.0006
677 HYPOAESTHESIA ORAL 9 0.0006
678 CYSTITIS 19 0.0006
679 JOINT RANGE OF MOTION DECREASED 8 0.0006
680 OROPHARYNGEAL PAIN 55 0.0006
681 MUSCULOSKELETAL PAIN 31 0.0006
682 WHEEZING 35 0.0006
683 MOTOR DYSFUNCTION 6 0.0006
684 ACCIDENT 7 0.0006
685 PHOTOPHOBIA 11 0.0006
686 EAR DISCOMFORT 6 0.0006
687 THERAPY CESSATION 30 0.0006
688 INTESTINAL OBSTRUCTION 22 0.0006
689 PRODUCT STORAGE ERROR 51 0.0006
690 LIMB DISCOMFORT 18 0.0006
691 PROTEINURIA 11 0.0006
692 TREMOR 96 0.0006
693 MIGRAINE 55 0.0006
694 BLOOD PRESSURE INCREASED 88 0.0006
695 FEELING COLD 16 0.0006
696 POST PROCEDURAL COMPLICATION 11 0.0006
697 CHEST PAIN 106 0.0006
698 FEELING ABNORMAL 137 0.0006
699 EOSINOPHILIA 10 0.0006
700 OXYGEN SATURATION DECREASED 32 0.0006
701 HYPOAESTHESIA 85 0.0006
702 MEMORY IMPAIRMENT 78 0.0006
703 SCIATICA 9 0.0006
704 HAEMORRHOIDS 11 0.0006
705 EAR INFECTION 15 0.0006
706 GASTROINTESTINAL HAEMORRHAGE 47 0.0006
707 IMPAIRED WORK ABILITY 12 0.0006
708 MUSCLE SPASMS 103 0.0006
709 HYPOACUSIS 24 0.0006
710 DISABILITY 11 0.0006
711 BLOOD PRESSURE ABNORMAL 11 0.0006
712 HYPERHIDROSIS 71 0.0006
713 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
714 INTENTIONAL PRODUCT USE ISSUE 48 0.0005
715 PRODUCTIVE COUGH 26 0.0005
716 ILLNESS 56 0.0005
717 PAIN IN EXTREMITY 160 0.0005
718 CYTOMEGALOVIRUS INFECTION 9 0.0005
719 GAIT INABILITY 18 0.0005
720 NECK PAIN 30 0.0005
721 WOUND 15 0.0005
722 HAEMORRHAGE INTRACRANIAL 8 0.0005
723 PRESYNCOPE 13 0.0005
724 INFLUENZA LIKE ILLNESS 44 0.0005
725 DIZZINESS 266 0.0005
726 INCORRECT PRODUCT STORAGE 7 0.0005
727 THERAPY INTERRUPTED 38 0.0005
728 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15 0.0005
729 BLOOD URINE PRESENT 10 0.0005
730 INJURY 37 0.0005
731 FEELING JITTERY 10 0.0005
732 MUSCULOSKELETAL DISCOMFORT 9 0.0005
733 HERPES ZOSTER 30 0.0005
734 CHOLELITHIASIS 17 0.0005
735 IMPAIRED HEALING 17 0.0005
736 RENAL DISORDER 24 0.0005
737 MOBILITY DECREASED 37 0.0005
738 EAR PAIN 10 0.0005
739 DRUG TOXICITY 7 0.0005
740 SWELLING 48 0.0005
741 CARDIOVASCULAR DISORDER 13 0.0005
742 RECTAL HAEMORRHAGE 22 0.0005
743 HEADACHE 321 0.0005
744 VIRAL INFECTION 17 0.0005
745 BRAIN FOG 8 0.0005
746 COUGH 143 0.0005
747 KIDNEY INFECTION 10 0.0005
748 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
749 LOSS OF CONSCIOUSNESS 65 0.0005
750 FEELING HOT 31 0.0005
751 ISCHAEMIC STROKE 9 0.0005
752 HOT FLUSH 38 0.0005
753 TRANSIENT ISCHAEMIC ATTACK 17 0.0005
754 RASH GENERALISED 13 0.0005
755 MOOD SWINGS 16 0.0005
756 HEPATITIS C 6 0.0005
757 INTENTIONAL SELF-INJURY 10 0.0005
758 RESTLESS LEGS SYNDROME 9 0.0005
759 TOOTH DISORDER 11 0.0005
760 BLOOD POTASSIUM INCREASED 8 0.0005
761 BACK DISORDER 8 0.0005
762 EPILEPSY 15 0.0005
763 RENAL IMPAIRMENT 41 0.0005
764 HEART RATE IRREGULAR 11 0.0005
765 LUNG NEOPLASM MALIGNANT 20 0.0005
766 PARAESTHESIA ORAL 7 0.0005
767 HYPERTHYROIDISM 7 0.0005
768 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
769 MIDDLE INSOMNIA 9 0.0005
770 HYPERTENSION 102 0.0005
771 SUICIDAL IDEATION 44 0.0005
772 NERVOUS SYSTEM DISORDER 15 0.0005
773 TINNITUS 22 0.0005
774 DYSPEPSIA 47 0.0005
775 DERMATITIS ALLERGIC 6 0.0005
776 ABDOMINAL DISCOMFORT 80 0.0005
777 HOSPITALISATION 73 0.0005
778 GASTRIC CANCER 12 0.0005
779 HALLUCINATION, VISUAL 10 0.0005
780 DRUG WITHDRAWAL SYNDROME NEONATAL 7 0.0005
781 SKIN HAEMORRHAGE 7 0.0005
782 HEPATIC ENZYME INCREASED 32 0.0005
783 DRUG PRESCRIBING ERROR 9 0.0005
784 IRRITABLE BOWEL SYNDROME 10 0.0005
785 DRUG INTOLERANCE 45 0.0005
786 ERUCTATION 9 0.0005
787 PRESCRIBED OVERDOSE 9 0.0005
788 POOR QUALITY SLEEP 10 0.0005
789 BLISTER 26 0.0005
790 MULTI-ORGAN FAILURE 8 0.0005
791 DIPLOPIA 12 0.0005
792 PERIPHERAL SWELLING 71 0.0005
793 WEIGHT INCREASED 103 0.0005
794 DEVICE FAILURE 7 0.0005
795 DEAFNESS 12 0.0005
796 LOCAL SWELLING 8 0.0005
797 SEDATION 12 0.0005
798 BEDRIDDEN 6 0.0005
799 IMMUNE SYSTEM DISORDER 6 0.0005
800 CONDITION AGGRAVATED 138 0.0005
801 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
802 BRADYCARDIA 24 0.0005
803 FIBROMYALGIA 11 0.0005
804 RASH 197 0.0005
805 DELUSION 7 0.0005
806 LIP SWELLING 15 0.0004
807 HAIR TEXTURE ABNORMAL 6 0.0004
808 GLOSSODYNIA 10 0.0004
809 THROAT IRRITATION 20 0.0004
810 ABASIA 11 0.0004
811 PANCREATITIS ACUTE 10 0.0004
812 VISION BLURRED 61 0.0004
813 FREQUENT BOWEL MOVEMENTS 12 0.0004
814 THROAT TIGHTNESS 12 0.0004
815 BONE MARROW FAILURE 9 0.0004
816 MALAISE 194 0.0004
817 TOOTHACHE 8 0.0004
818 ACUTE MYOCARDIAL INFARCTION 13 0.0004
819 ULCER 7 0.0004
820 PARAESTHESIA 69 0.0004
821 METABOLIC ACIDOSIS 14 0.0004
822 INFUSION RELATED REACTION 29 0.0004
823 DEPRESSED MOOD 23 0.0004
824 NEOPLASM MALIGNANT 29 0.0004
825 NASOPHARYNGITIS 80 0.0004
826 RHINORRHOEA 28 0.0004
827 DRUG WITHDRAWAL SYNDROME 38 0.0004
828 HYPOGLYCAEMIA 21 0.0004
829 DIABETES MELLITUS 33 0.0004
830 IRRITABILITY 26 0.0004
831 PRODUCT USE IN UNAPPROVED INDICATION 107 0.0004
832 CHEST DISCOMFORT 44 0.0004
833 VISUAL IMPAIRMENT 53 0.0004
834 SKIN ULCER 11 0.0004
835 ARRHYTHMIA 20 0.0004
836 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
837 SKIN DISORDER 14 0.0004
838 JOINT STIFFNESS 11 0.0004
839 CARDIOGENIC SHOCK 6 0.0004
840 ALOPECIA 82 0.0004
841 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
842 BLOOD PRESSURE FLUCTUATION 10 0.0004
843 SWOLLEN TONGUE 13 0.0004
844 ANGER 14 0.0004
845 MEDICATION ERROR 23 0.0004
846 CIRCULATORY COLLAPSE 7 0.0004
847 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
848 SURGERY 24 0.0004
849 SCAR 7 0.0004
850 POLLAKIURIA 17 0.0004
851 MOVEMENT DISORDER 13 0.0004
852 MOOD ALTERED 11 0.0004
853 HEART RATE DECREASED 14 0.0004
854 CARDIAC FAILURE 32 0.0004
855 CARDIAC FAILURE CONGESTIVE 32 0.0004
856 ARTHRALGIA 160 0.0004
857 PALPITATIONS 45 0.0004
858 CYANOSIS 6 0.0004
859 DRY EYE 19 0.0004
860 HAEMATOCHEZIA 21 0.0004
861 ASTHMA 43 0.0004
862 PRODUCT PRESCRIBING ERROR 9 0.0004
863 THINKING ABNORMAL 7 0.0004
864 DRY SKIN 50 0.0004
865 JOINT INJURY 8 0.0004
866 FAECES DISCOLOURED 8 0.0004
867 PRODUCT DOSE OMISSION 24 0.0004
868 ADVERSE DRUG REACTION 33 0.0004
869 ABNORMAL DREAMS 10 0.0004
870 MYOCARDIAL INFARCTION 63 0.0004
871 WRONG TECHNIQUE IN DRUG USAGE PROCESS 13 0.0004
872 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
873 DRUG-INDUCED LIVER INJURY 11 0.0004
874 ANGINA PECTORIS 10 0.0003
875 PRODUCT PHYSICAL ISSUE 7 0.0003
876 PRODUCT DOSE OMISSION ISSUE 101 0.0003
877 DYSPHONIA 20 0.0003
878 LIVER DISORDER 15 0.0003
879 CEREBROVASCULAR ACCIDENT 57 0.0003
880 MYALGIA 57 0.0003
881 FEAR 9 0.0003
882 PAIN OF SKIN 9 0.0003
883 VISUAL ACUITY REDUCED 11 0.0003
884 MUSCULOSKELETAL STIFFNESS 29 0.0003
885 INFLAMMATION 17 0.0003
886 SKIN LESION 9 0.0003
887 SKIN CANCER 7 0.0003
888 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 23 0.0003
889 JOINT SWELLING 39 0.0003
890 AGRANULOCYTOSIS 6 0.0003
891 SWELLING FACE 21 0.0003
892 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 58 0.0003
893 GASTRIC DISORDER 11 0.0003
894 BLINDNESS 13 0.0003
895 NIGHTMARE 11 0.0003
896 MUSCULOSKELETAL DISORDER 6 0.0003
897 COMA 15 0.0003
898 ADVERSE EVENT 29 0.0003
899 HEPATOTOXICITY 7 0.0003
900 HEPATITIS 8 0.0003
901 ERECTILE DYSFUNCTION 8 0.0003
902 DISCOMFORT 19 0.0003
903 PRODUCT ADHESION ISSUE 11 0.0003
904 PRODUCT AVAILABILITY ISSUE 7 0.0003
905 DRUG DOSE OMISSION 50 0.0003
906 DEVICE DISLOCATION 13 0.0003
907 URTICARIA 50 0.0003
908 SKIN EXFOLIATION 25 0.0003
909 DIABETIC KETOACIDOSIS 7 0.0003
910 ANAPHYLACTIC REACTION 16 0.0003
911 NASAL CONGESTION 17 0.0003
912 CARDIAC DISORDER 27 0.0003
913 DERMATITIS 6 0.0003
914 FLUSHING 29 0.0003
915 ERYTHEMA 58 0.0003
916 ILL-DEFINED DISORDER 17 0.0003
917 CEREBRAL HAEMORRHAGE 10 0.0003
918 HAEMORRHAGE 29 0.0003
919 ABDOMINAL PAIN LOWER 7 0.0003
920 DYSSTASIA 8 0.0003
921 RASH ERYTHEMATOUS 13 0.0003
922 BURNING SENSATION 19 0.0003
923 BLOOD GLUCOSE DECREASED 13 0.0003
924 THERAPEUTIC PRODUCT EFFECT DECREASED 12 0.0003
925 EYE PRURITUS 9 0.0003
926 RESPIRATORY DISORDER 8 0.0003
927 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 19 0.0003
928 CORONARY ARTERY DISEASE 8 0.0003
929 RHABDOMYOLYSIS 11 0.0003
930 PRURITUS 100 0.0003
931 EMOTIONAL DISORDER 8 0.0003
932 RASH PRURITIC 14 0.0003
933 RASH MACULAR 9 0.0003
934 BLOOD CHOLESTEROL INCREASED 12 0.0003
935 TREATMENT NONCOMPLIANCE 14 0.0003
936 PRODUCT USE ISSUE 48 0.0003
937 ARTHRITIS 20 0.0003
938 PROCEDURAL PAIN 7 0.0003
939 DRUG INEFFECTIVE 329 0.0002
940 INTENTIONAL OVERDOSE 16 0.0002
941 EYE PAIN 14 0.0002
942 THERAPY NON-RESPONDER 11 0.0002
943 LIVER INJURY 6 0.0002
944 DRUG EFFECT DECREASED 13 0.0002
945 TYPE 2 DIABETES MELLITUS 8 0.0002
946 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
947 VAGINAL HAEMORRHAGE 10 0.0002
948 DRUG ADMINISTRATION ERROR 7 0.0002
949 FEMUR FRACTURE 7 0.0002
950 PRODUCT SUBSTITUTION ISSUE 13 0.0002
951 HYPERSENSITIVITY 41 0.0002
952 HEPATIC FUNCTION ABNORMAL 8 0.0002
953 EYE DISORDER 7 0.0002
954 BLOOD GLUCOSE INCREASED 40 0.0002
955 NERVOUSNESS 11 0.0002
956 FOETAL EXPOSURE DURING PREGNANCY 17 0.0002
957 DEVICE LEAKAGE 9 0.0002
958 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
959 SUICIDE ATTEMPT 12 0.0002
960 CRYING 7 0.0002
961 UNDERDOSE 14 0.0002
962 DISEASE RECURRENCE 9 0.0002
963 CATARACT 11 0.0002
964 ANGIOEDEMA 8 0.0002
965 INCORRECT DOSE ADMINISTERED 40 0.0002
966 PSORIATIC ARTHROPATHY 7 0.0002
967 TREATMENT FAILURE 14 0.0002
968 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
969 INJECTION SITE BRUISING 13 0.0002
970 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 33 0.0002
971 PROSTATE CANCER 12 0.0001
972 EXTRA DOSE ADMINISTERED 6 0.0001
973 RENAL CANCER 7 0.0001
974 ARTHROPATHY 8 0.0001
975 NO ADVERSE EVENT 26 0.0001
976 INJECTION SITE PRURITUS 9 0.0001
977 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
978 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
979 INJECTION SITE PAIN 36 0.0001
980 INJECTION SITE REACTION 8 0.0001
981 RHEUMATOID ARTHRITIS 13 0.0001
982 INJECTION SITE HAEMORRHAGE 9 0.0001
983 SKIN BURNING SENSATION 8 0.0001
984 PRODUCT QUALITY ISSUE 15 0.0001
985 ACNE 8 0.0001
986 INJECTION SITE SWELLING 8 0.0001
987 EYE IRRITATION 6 0.0001
988 DEVICE MALFUNCTION 7 0.0001
989 BREAST CANCER 9 0.0001
990 DEVICE ISSUE 8 0.0001
991 INJECTION SITE ERYTHEMA 10 0.0001
992 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
993 PSORIASIS 8 0.0001